18 F-Fluoride PET-CT offers the opportunity for accurate skeletal metastasis staging compared to conventional imaging methods.
morphologically in CT images due to the resulting increase in bone mineralization and sclerosis. Whilst CT is characterized by high resolution, the potential of PET is limited by its lower spatial resolution and the resulting partial volume effect. In this context, the synergy between PET and CT presents an opportunity to resolve this limitation using a novel multimodal approach called Synergistic-Functional-Structural Resolution-Recovery (SFS-RR). Its performance is benchmarked against current resolution recovery technology employing the point-spread-function (PSF) of the scanner in the reconstruction procedure.
Methods -The SFS-RR technique takes advantage of the multiresolution property of the wavelet transform applied to both functional and structural images to create a highresolution PET that exploits the structural information of CT. Although the method was originally conceived for PET-MRI brain data, an ad-hoc version for whole body PET-CT is here proposed.
Three phantom experiments and two datasets of metastatic bone 18 F-Fluoride PET-CT images from primary prostate and breast cancer were used to test the algorithm performances. The SFS-RR images were compared with the manufacturerÕs PSF based reconstruction using the standardized uptake value (SUV) and the metabolic volume as metrics for quantification.
Results Ð When compared to standard PET images the phantom experiments showed a bias reduction of 14% in activity and 1.3cm 3 in volume estimates for PSF images and up to 20% and 2.5cm 3 for the SFS-RR images. The SFS-RR images were characterized by a higher recovery coefficient (up to 60%) while noise levels remained comparable to those of standard PET.
The clinical data showed an increase in the SUV estimates for SFS-RR images up to 34%
for SUV peak and 50% for SUV max and SUV mean . Images were also characterized by sharper lesion contours and better lesion detectability.
INTRODUCTION
Up to 70% of patients with prostate and breast cancer will develop bone metastases (1, 2) . 18 F-Fluoride has shown efficacy in both diagnosis and treatment response assessment (3) (4) (5) (6) and recent studies on skeletal metastases report improved diagnostic sensitivity and specificity when morphologic evaluation from computed tomography (CT) scans are combined with functional evaluation of 18 F-Fluoride positron emission tomography (PET) (7, 8) . This radiotracer accumulates at skeletal metastatic sites as a result of increased blood flow, osteoblastic activity and bone mineralization (9) (10) (11) . In prostate cancer, 18 F-Fluoride accumulation corresponds to sites of osteosclerosis and increased bone density that are usually visible on CT (12).
Evaluation criteria for tumor staging and response assessment include visual and/or quantitative evaluation of the extent, intensity and changes in 18 F-Fluoride uptake in bone lesions (13) . In this perspective the influence of the partial volume effect (PVE) is of impact (14) when comparing activity and morphological changes pre-and post-therapy In this study our aim was to correct for the PVE in whole-body 18 F-Fluoride PET-CT to allow a more robust lesion classification in terms of activity quantification and volume definition. The methodology was developed from previous work by Shidahara et al 
MATERIALS AND METHODS

Image Resolution Recovery
The Synergistic-Functional-Structural Resolution-Recovery (SFS-RR) algorithm was first introduced by Shidahara et al. (20) for partial volume correction of brain PET-MR data. The structural information was exploited by segmenting a T1-MRI image through a probability atlas (26) defining 83 anatomical regions. Hence, the resolution recovery is ROI-based and relies on good co-registration between PET and MRI images as well as between MRI and the probability atlas. The idea stems from previous concepts on waveletbased resolution recovery (19) and de-noising (27).
In this work we developed SFS-RR further to fit a novel clinical requirement, and, secondly, they do not require additional coregistration as for two separate PET and MR acquisitions. Furthermore all the structural information of interest is contained in the CT and can be automatically segmented for each subject with no need for a universal atlas.
The algorithm decomposes both functional (PET) and anatomical (CT) images into several resolution elements by means of a wavelet transform. The high-resolution components of both modalities are then combined together via a statistical model with appropriate scaling, resolution correction and weighting, to create a high-resolution PET image that exploits the structural information, when present, but preserves PET data when matching structural data are not present.
Anatomical Image Segmentation
In their original work, Shidahara et al. (20) proposed the use of an anatomical brain atlas to obtain suitable anatomical images. In brain studies this is a reasonable procedure given the possibility of normalizing to a common space (e.g. probabilistic atlas).
In whole-body PET-CT, the atlas-based approach is not feasible. In Image segmentation and the SFS-RR algorithm implementation were both performed in Matlab R2011b (The Mathworks Inc., Natick MA, USA). The whole procedure is schematically described in Figure 1 ; for a more detailed mathematical exposition the reader is referred to the Supplementary Materials (Synergistic-FunctionalStructural Resolution Recovery Algorithm section).
Phantom Data
For the evaluation of the SFS-RR method we used the NEMA IEC body phantom 
PET-PSF).
All the images were finally smoothed with a Gaussian 3D filter FWHM 6.4mm; this is required by PSF reconstructed images as well when used in clinical routine given that increased noise level hamper visual assessment.
Clinical Dataset
The impact of the proposed resolution recovery technique was tested with two different sets of oncological patient data, both characterized by the presence of bone metastases. The institutional review board approved this study and all subjects signed a written informed consent.
The first dataset was a prospective observational study of patients with bonepredominant metastatic prostate cancer, at first diagnosis or at progression of disease, who were embarking on docetaxel chemotherapy. The second data set was a prospective observational study of patients with bone-predominant metastatic breast cancer, at first diagnosis or at progression of disease, who were embarking on a new line of endocrine treatment in combination with bone-targeted therapy. In total 7 patients with active skeletal metastases were included in the analysis, 4 with prostate cancer and 3 with breast cancer.
In each patient a whole body 18 F-Fluoride PET-CT scan was acquired with a total of 8 bed positions, from the base of the skull to upper thighs, 60 minutes after injection of approximately 250MBq.
The image reconstruction protocol for both datasets was the same as for the phantom experiment, with the exclusion of the PSF reconstruction, which was not performed as it was not included in the clinical protocol.
Data Analysis
In-house software was used to perform quantitative analysis on both phantom and patient
data. An ROI was manually drawn on the outer border of each lesion in order to completely contain the whole lesion volume (or sphere for the phantom data) and then automatically segmented with a threshold of 40% of the maximum value of the ROI. The SUV mean , SUV max , SUV peak and lesion metabolic active tumor volume (MATV) were then computed for the automatically segmented ROI. SUV peak is computed here as the mean SUV measured over a fixed small circular volume of about 1cm 3 , in the hottest area of the tumor (more active region). It is considered more reproducible since it involves the mean value of a few voxels involving and surrounding the hottest tumor area.
Solely for the phantom experiments, knowing the ground truth, we used the Root Mean Square Error (RMSE) and Contrast to Noise Ratio (CNR) as additional metrics for image quality assessment. Specifically, we evaluated the quantification accuracy and the trade-off between contrast improvement and image noise. The two metrics are defined as follow
! ! !represents the mean activity estimated inside a sphere and ! !!!∀#∃ ! the corresponding ground truth while ! !∀#∃ !is the mean activity estimated in the phantom background and ! !∀# its standard deviation. Improved qualitative resolution for the smaller structures (red marker in Figure 2 ) is noted when the SFS-RR algorithm is applied. Even though larger spheres (green and blue markers in Figure 2 ) are easily detectable in the images from all modalities, it is possible to appreciate a reduction in the blurring surrounding the structure when the resolution recovery algorithm is implemented.
RESULTS
Phantom Data
Furthermore it is possible to appreciate the robustness of the anatomy-based resolution recovery algorithm to unexpected mismatches between anatomy and functional acquisition by studying images from Experiment 1. Even though spheres 4-6 cannot be detected on the CT they are not lost in the new functional image returned by the SFS-RR algorithm.
The quantitative evaluation of functional images obtained with the three different methods is reported in Table 2. The table reports 
Clinical Dataset
The influence of using the SFS-RR algorithm on real patient data can be appreciated qualitatively in Figure 4 (and Figures 4-6 in Supplementary Materials) where the Maximum Intensity Projection (MIP) and two different transaxial views are displayed for a representative subject.
There is a clear increase in lesion sharpness following the application of a resolution recovery technique. The quantitative characterization of all lesions of this specific subject is reported in the Supplementary Materials ( Figure 7 and Table 1 ). The transaxial views of A comprehensive comparison of the quantitative differences due to application of the SFS-RR algorithm is reported in Figure 5 . As previously performed for Patient 01 ( Figure 7 - Table 1 Supplementary Materials) we segmented all lesions of the remaining patients and collected the corresponding values of SUV mean , SUV max , SUV peak and MATV. Figure 5 reports the relative differences (SUVs and MATV) between lesions segmented in standard PET and PET-SFS images for the entire datasets.
There is a general increment in activity estimates for PET-SFS compared to standard PET.
The average increments for different indexes are as follow: ΔSUV mean = 49%, ΔSUV max = 47% and ΔSUV peak = 34%. For low activity lesions the range of differences in the estimates is larger than for more active lesions indicating that the algorithm efficiency is dependent on signal to noise ratio. depend on image noise, the 50% increase is not a consequence of noise bursts given the comparable RMSE between the SFS-RR corrected images and standard PET images.
The higher activity recovery and the good noise control from the phantom analysis indicate a better image quality when the SFS-RR algorithm is applied. Indeed patient images show lesions with sharper and better-defined contours, which result in improved lesion conspicuity and segmentation even for smaller volumes. To note that the CNR depends on the absolute activity value and that explains why on Figure 3 one set of spheres show higher CNR than the other.
The results from the phantom experiments showed that the SFS-RR images outperform both standard PET and PSF images in terms of image quality and quantification accuracy. PSF-based image reconstruction is known to contribute to the appearance of artefacts (33) and is computationally cumbersome hence is not performed in routine clinical studies in our Unit; for this reason standard PET was used as a reference for SFS-RR images when it came to patients image analysis. In this regard, it is worth noting that no artefacts have been generally observed in this and previous applications of SFS-RR which is now a mature enough technology worth further testing in the clinical setting.
It is worth highlighting the robustness of the methodology regarding possible mismatch between PET and CT images. Phantom acquisitions showed that even if some structures are only visible on the functional images, they are preserved after the application of the algorithm. This is of importance because lesions that might be lost in the CT segmentation, for example because their size is too small or the metastasis does not show sufficient bone mineralization to appear sclerotic, they will still be visible in the final enhanced PET images.
Although the SFS-RR algorithm showed qualitatively and quantitatively better images than standard PET, further analyses are necessary to quantify the influence of the improved image quality on the assessment of patient skeletal staging and therapy response.
This may allow better definition and quantification of lesions following therapy or allow greater detectability and segmentation of metastatic spread at staging. Of interest would be also to evaluate whether lesion heterogeneity is affected by higher resolution and evaluate the consequent impact on textural analysis, given its increasing oncological applications (34, 35).
CONCLUSION
We have proposed and tested on a set of phantom studies and demonstrated on clinical data a multimodal methodology for quantitative resolution recovery for whole body PET-CT, here specifically designed for 18 F-Fluoride PET imaging of bone metastases. The technique allows rapid and straightforward application and produces images of significant improved visual quality and quantitative properties.
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